COVID-19:
COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
Español |
COVID-19 resources for global health researchers
NIH Global Health Funding
In addition to
Fogarty-supported programs and the
trans-NIH programs and collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.
Current Global Health Funding Opportunities from Across NIH
Expire in 2021
- Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (RFA-CA-21-056)
Expiration Date: December 16, 2021 - NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01 Clinical Trial Optional) (RFA-DK-21-022)
Expiration Date: December 22, 2021 - Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) (RFA-CA-21-046) Expiration Date: December 29, 2021
Expire in 2022
- Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) (RFA-MH-22-105)
Expiration Date: January 7, 2022 - Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) (RFA-MH-22-106)
Expiration Date: January 7, 2022 - Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) (RFA-AI-21-065)
Expiration Date: January 15, 2022 - Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-22-004) Expiration Date: January 19, 2022
- Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-22-005)
Expiration Date: January 20, 2022
- Role of Astrocytes in Degeneration of the Neurovascular Unit in Alzheimer’s disease (AD)/AD-related dementias (ADRDs) (R01 Clinical Trial Not Allowed) (PAR-22-037)
Expiration Date: February 5, 2022 - Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) (RFA-AI-21-075)
Expiration Date: February 9, 2022 - Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional) (RFA-DA-22-028)
Expiration Date: February 10, 2022 - Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional) (RFA-DA-22-039)
Expiration Date: February 10, 2022
- Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed) (RFA-EY-21-002)
Expiration Date: February 18, 2022
- Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) ( RFA-AI-21-070 )
Expiration Date: February 19, 2022 - Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) (PAR-22-054)
Expiration Date: February 24, 2022 - Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) (RFA-AG-23-001)
Expiration Date: March 4, 2022 - Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) (RFA-AG-23-002)
Expiration Date: March 4, 2022 - Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) (PAR-22-048)
Expiration Date: March 12, 2022 - Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required) (RFA-HD-22-017)
Expiration Date: March 31, 2022 - Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) (RFA-HD-22-023)
Expiration Date: March 31, 2022 - Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) (RFA-HD-23-005)
Expiration Date: March 31, 2022 - Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) (RFA-RM-22-006)
Expiration Date: June 11, 2022 - Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (RFA-CA-22-003)
Expiration Date: September 23, 2022 - Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-22-004)
Expiration Date: September 23, 2022 - Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 ClinicalTrial Not Allowed) (RFA-CA-22-001)
Expiration Date: September 23, 2022 - Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (RFA-CA-22-002)
Expiration Date: September 23, 2022
Expire in 2023
- Co-infection and Cancer
(R01 Clinical Trial Not Allowed) (PAR-20-062) and
(R21 Clinical Trial Not Allowed) (PAR-20-061)
Expiration Date: January 8, 2023
- Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) (RFA-MH-22-150)
Expiration Date: February 23, 2023. - Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (NOT-CA-20-022)
Expiration Date: January 8, 2023
- Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions
(G11 Clinical Trial Not Allowed) (PAR-21-037)
Expiration Date: July 29, 2023 - Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) (PAR-21-342)
Expiration Date: December 14, 2023 - The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) ( PAR-21-348 )
Expiration Date: December 16, 2023
Expire in 2024
- Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) (PAR-21-343)
Expiration Date: April 19, 2024 - Notice of Special Interest (NOSI) in Reducing Suicide Risk in Young People in Low- and Middle-Income Countries and Low-Resource Settings (NOT-MH-21-090)
Expiration date: May 8, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) ( PAR-21-349 )
Expiration Date: June 22, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) ( PAR-21-350 )
Expiration Date: June 22, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) ( PAR-21-349 )
Expiration Date: June 22, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) ( PAR-21-350 )
Expiration Date: June 22, 2024 - NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) (PAR-21-228)
Note: NIMH encourages U.S.-based applications with Low- and Middle-Income Country (LMIC) sites.
Expiration Date: September 8, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required) ( PAR-21-352 )
Expiration Date: September 8, 2024 - Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required) ( PAR-21-352 )
Expiration Date: September 8, 2024 - Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) (PAR-22-049)
Expiration Date: September 14, 2024. - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) ( PAR-21-341 )
Expiration Date: October 9, 2024 - Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) (PAR-21-353)
Expiration Date: November 6, 2024 - Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) (PAR-21-354)
Expiration Date: November 17, 2024 - Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) (PAR-21-355)
Expiration: November 17, 2024
Expire in 2025
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) ( PAR-22-038 )
Expiration Date: January 8, 2025 - Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) ( PAR-22-039 )
Expiration Date: January 8, 2025 - Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) (PAR-22-061)
Expiration Date: January 8, 2025 - Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) (PAR-22-062)
Expiration Date: January 8, 2025 - Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) (PAR-22-066)
Expiration Date: January 8, 2025. - Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed) (PAR-22-067)
Expiration Date: January 8, 2025. - NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) (PAR-22-070)
Expiration Date: January 8, 2025.
Other NIH global health funding resources
Updated November 29, 2021